444
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis

, &
Pages 369-377 | Received 30 Jul 2010, Accepted 01 Nov 2010, Published online: 23 Jan 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Filippo Migliorini, Giorgia Colarossi, Alice Baroncini, Jörg Eschweiler, Markus Tingart & Nicola Maffulli. (2021) Pharmacological Management of Postmenopausal Osteoporosis: a Level I Evidence Based - Expert Opinion. Expert Review of Clinical Pharmacology 14:1, pages 105-119.
Read now

Articles from other publishers (16)

Priya Jaisinghani, Anupa Sharma & Xiangbang Wang. (2022) Primary hyperparathyroidism in the geriatric population: A case report and mini literature review. Clinical Case Reports 10:11.
Crossref
Ronni Baran, Markus Wehland, Herbert Schulz, Martina Heer, Manfred Infanger & Daniela Grimm. (2022) Microgravity-Related Changes in Bone Density and Treatment Options: A Systematic Review. International Journal of Molecular Sciences 23:15, pages 8650.
Crossref
Hiroaki Tagomori, Nobuhiro Kaku, Shota Sato, Tsuguaki Hosoyama & Hiroshi Tsumura. (2022) Contemporaneous Insufficiency Fractures of Bilateral Femoral Necks in an Older Patient Taking Bisphosphonate: A Case Report and Literature Review. Case Reports in Orthopedics 2022, pages 1-5.
Crossref
Filippo Migliorini, Nicola Maffulli, Filippo Spiezia, Giuseppe Maria Peretti, Markus Tingart & Riccardo Giorgino. (2021) Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review. Journal of Orthopaedic Surgery and Research 16:1.
Crossref
Pawel Szulc, Douglas C. Bauer & Richard Eastell. 2021. Marcus and Feldman's Osteoporosis. Marcus and Feldman's Osteoporosis 1545 1588 .
Sarah Davis, Emma Simpson, Jean Hamilton, Marrissa Martyn-St James, Andrew Rawdin, Ruth Wong, Edward Goka, Neil Gittoes & Peter Selby. (2020) Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation. Health Technology Assessment 24:29, pages 1-314.
Crossref
Benjamin Z. Leder. 2020. Osteoporosis. Osteoporosis 363 374 .
Benjamin Z. Leder & Joy N. Tsai. 2019. Encyclopedia of Endocrine Diseases. Encyclopedia of Endocrine Diseases 281 287 .
Joy N. Tsai & Benjamin Z. Leder. 2018. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 567 572 .
Gui‐Feng Liu, Zong‐Qiang Wang, Lin Liu, Bu‐Tian Zhang, Ying‐Ying Miao & Shao‐Nan Yu. (2018) A network meta‐analysis on the short‐term efficacy and adverse events of different anti‐osteoporosis drugs for the treatment of postmenopausal osteoporosis. Journal of Cellular Biochemistry 119:6, pages 4469-4481.
Crossref
Jungmee Kim, Ju-Young Shin, Joongyub Lee, Hong-Ji Song, Nam-Kyong Choi & Byung-Joo Park. (2015) Comparison of the Prescribing Pattern of Bisphosphonate and Raloxifene in Korean Women with Osteoporosis: From a National Health Insurance Claims Database. PLOS ONE 10:6, pages e0127970.
Crossref
Benjamin Z. Leder. 2015. The Parathyroids. The Parathyroids 853 863 .
Tiao Lin, Shi-Gui Yan, Xun-Zi Cai, Zhi-Min Ying, Fu-Zhen Yuan & Xi Zuo. (2014) Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials. International Journal of Endocrinology 2014, pages 1-16.
Crossref
Pawel Szulc & Douglas C. Bauer. 2013. Osteoporosis. Osteoporosis 1573 1610 .
Pawel Szulc. (2012) The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis. Clinical Biochemistry 45:12, pages 907-919.
Crossref
Peter Vestergaard. (2012) Raloxifene for the treatment of postmenopausal osteoporosis. International Journal of Clinical Rheumatology 7:3, pages 261-269.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.